Allurion Technologies today announced the relaunch of its Allurion Balloon in France following regulatory clearance to resume ...

Allurion’s CEO confirmed to Medical Device Network that the company has changed advertising, patient follow-up, and physician ...

Allurion Technologies (ALUR) announced that it is relaunching the Allurion Balloon in France after ANSM, the French regulatory authority, ...

The Allurion swallowable intragastric balloon offers a safe, effective and minimally invasive method of losing weight.

Shares of Allurion (NYSE:ALUR) soared 70% in post-market trading Thursday after ... balloon weight-loss product in combination with GLP-1 drugs. Allurion (NYSE:ALUR) announced about ten minutes ...

Allurion (NYSE: ALUR) surged 83% premarket after revealing a clinical study combining its gastric balloon product with GLP-1 drugs, showing muscle mass maintenance. Stardust Power (NASDAQ ...

Unlike other approaches, Allurion’s balloon does not require surgery, endoscopy, or anaesthesia. After around four months, the balloon releases the liquid on its own and it passes out of the ...

James Manning / PA Images via Getty Images Allurion Technologies said it planned to test its gastric balloon with the key ... something to cheer about after they watched the shares sink rapidly ...